These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
378 related items for PubMed ID: 12196897
1. Chemotherapy in the post-MVAC era: the case for adjuvant chemotherapy. Lehmann J, Retz M, Stöckle M. World J Urol; 2002 Aug; 20(3):144-50. PubMed ID: 12196897 [Abstract] [Full Text] [Related]
2. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer. Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M. BJU Int; 2006 Jan; 97(1):42-7. PubMed ID: 16336326 [Abstract] [Full Text] [Related]
3. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer. Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M. Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818 [Abstract] [Full Text] [Related]
4. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy]. Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H. Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259 [Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline. Segal R, Winquist E, Lukka H, Chin JL, Brundage M, Markman BR, Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group. Can J Urol; 2002 Oct; 9(5):1625-33. PubMed ID: 12431323 [Abstract] [Full Text] [Related]
7. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma. Soga N, Arima K, Sugimura Y. Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862 [Abstract] [Full Text] [Related]
8. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). Lehmann J, Retz M, Wiemers C, Beck J, Thüroff J, Weining C, Albers P, Frohneberg D, Becker T, Funke PJ, Walz P, Langbein S, Reiher F, Schiller M, Miller K, Roth S, Kälble T, Sternberg D, Wellek S, Stöckle M, AUO-AB 05/95. J Clin Oncol; 2005 Aug 01; 23(22):4963-74. PubMed ID: 15939920 [Abstract] [Full Text] [Related]
9. Treatment of invasive bladder cancer: lessons from the past and perspective for the future. Tsukamoto T, Kitamura H, Takahashi A, Masumori N. Jpn J Clin Oncol; 2004 Jun 01; 34(6):295-306. PubMed ID: 15333680 [Abstract] [Full Text] [Related]
10. Can patient selection for bladder preservation be based on response to chemotherapy? Sternberg CN, Pansadoro V, Calabrò F, Schnetzer S, Giannarelli D, Emiliozzi P, De Paula F, Scarpone P, De Carli P, Pizzo M, Platania A, Amini M. Cancer; 2003 Apr 01; 97(7):1644-52. PubMed ID: 12655521 [Abstract] [Full Text] [Related]
11. The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan. Matsui Y, Nishiyama H, Watanabe J, Teramukai S, Ono Y, Ohshima S, Fujimoto K, Hirao Y, Fukushima M, Ogawa O. Int J Clin Oncol; 2005 Apr 01; 10(2):133-8. PubMed ID: 15864700 [Abstract] [Full Text] [Related]
12. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer. Nieuwenhuijzen JA, Bex A, Meinhardt W, Kerst JM, Schornagel JH, VAN Tinteren H, Horenblas S. J Urol; 2005 Jul 01; 174(1):80-5. PubMed ID: 15947583 [Abstract] [Full Text] [Related]
13. Chemotherapy practices and perspectives in invasive bladder cancer. Flechon A, Droz JP. Expert Rev Anticancer Ther; 2006 Oct 01; 6(10):1473-82. PubMed ID: 17069531 [Abstract] [Full Text] [Related]
14. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study. Walz J, Shariat SF, Suardi N, Perrotte P, Lotan Y, Palapattu GS, Gupta A, Bastian PJ, Rogers CG, Vazina A, Amiel GE, Sagalowsky AI, Schoenberg M, Lerner SP, Karakiewicz PI. BJU Int; 2008 Jun 01; 101(11):1356-61. PubMed ID: 18454792 [Abstract] [Full Text] [Related]
15. Update on chemotherapy for advanced bladder cancer. Rosenberg JE, Carroll PR, Small EJ. J Urol; 2005 Jul 01; 174(1):14-20. PubMed ID: 15947569 [Abstract] [Full Text] [Related]
16. A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer. Wosnitzer MS, Hruby GW, Murphy AM, Barlow LJ, Cordon-Cardo C, Mansukhani M, Petrylak DP, Benson MC, McKiernan JM. Cancer; 2012 Jan 15; 118(2):358-64. PubMed ID: 21717438 [Abstract] [Full Text] [Related]
17. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer. Calabrò F, Sternberg CN. Eur Urol; 2009 Feb 15; 55(2):348-58. PubMed ID: 18977070 [Abstract] [Full Text] [Related]
18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N. Urology; 2004 Sep 15; 64(3):488-93. PubMed ID: 15351577 [Abstract] [Full Text] [Related]
19. [Systemic chemotherapy in bladder cancer]. Sengeløv L, Kamby C, von der Maase H. Ugeskr Laeger; 1993 May 03; 155(18):1363-8. PubMed ID: 8497967 [Abstract] [Full Text] [Related]
20. Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer. Milowsky MI, Stadler WM, Bajorin DF. BJU Int; 2008 Nov 03; 102(9 Pt B):1339-44. PubMed ID: 19035902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]